Related to this topic: Leaflets | Support | Patient+ | UK Guidelines | Weblinks | Equipment | Books | Your Experience | Other resources | Glossaries
Print options:
Other options:
(what's this?)
PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.
Cellulitis
Cellulitis is an infection of the dermis and subcutaneous tissue that has poorly demarcated borders and is usually caused by Streptococcus or Staphylococcus but can be caused by a wide range of both aerobic and anaerobic bacteria.
- Cellulits is a common problem and a common presentation in primary care.
- Cellulitis is more common and more serious in individuals with underlying diseases such as diabetes, cancer, or immunodeficiency.1
- The most common bacteria that cause cellulitis in patients with a healthy immune system are Group A Beta Haemolytic Streptococcus (Streptococcus pyogenes) and Staphylococcus aureus.
- Rarely, gram-negative organisms, anaerobes, or fungi may cause cellulitis. However these organisms are more common causes in children, people with diabetes and immunocompromised individuals.2
- Cellulitis in infants is usually caused by bloodborne spread of group B Streptococcus (urgent admission is required).
- In children, Haemophilus influenzae was a frequent cause prior to the introduction of the HiB vaccination.
- Cellulitis occurring around surgical wounds less than 24 hours post-operatively may result from Group A Beta Haemolytic Streptococcus or Clostridium perfringens. C. perfringens produces gas, leading to crepitus on examination.
- Cellulitis is being seen with increasing frequency in HIV-infected patients.3
- More commonly seen on the lower limbs. In many cases there is an obvious precipitating skin lesion, such as a traumatic wound or ulcer, or other area of damaged skin, e.g. athlete's foot.
- Erythema, pain, swelling, and warmth.

- Oedema and erythema often gradually blend into the surrounding skin and so the margin of the affected area may be indistinct.
- Systemic symptoms (e.g. fever, malaise) may occur.
- Red lines streaking away from a cellulitic area represent progression of the infection into the lymphatic system. Localized adenopathy is commonly observed with lymphangitis.
- Crepitus is a sign of infection most commonly observed with anaerobic organisms.
Many other conditions are mistakenly diagnosed as cellulitis. If the 'infection' does not respond to antibiotics, consider a biopsy or urgent referral for a dermatology opinion.4
- Most patients with cellulitis do not require further investigation.
- Full blood count: often shows raised white cell count but white cell count may be reduced in patients with toxin-mediated disease.
- Blood cultures if significant systemic symptoms or if bacteraemia is suspected.
- Fine needle aspiration: from leading edge of lesion may assist in diagnosis.
- X-rays, CT scan or MRI if there is any concern about a foreign body in situ.
- If bullae or abscesses form, culturing the fluid from inside these lesions yields an organism in more than 90% of cases.
Any patient who is at risk (e.g. young child, immunocompromised) or any concern about the underlying nature of the infection or lack of progress requires admission to hospital.
Non-Drug
- Consider need for tetanus prophylaxis.
- Immobilization and elevation of involved limb.
- Clean wound site: irrigation, debride devitalized tissue.
- Incision and drainage if deep fluctuant pocket.
- Cool sterile saline dressings decrease pain.
Drugs
- Benzylpenicillin/phenoxymethylpenicillin plus flucloxacillin (or erythromycin alone if penicillin-allergic).
- In mild cellulitis flucloxacillin may be used as single drug treatment.
- Always add phenoxymethylpenicillin if severe or rapid deterioration.
- Discontinue flucloxacillin if streptococcal infection confirmed.5
- Substitute treatment with broad-spectrum antibacterials if gram-negative bacteria or anaerobes are suspected.
- In facial cellulitis, use co-amoxiclav.6
Surgical
- Any patient with crepitus, circumferential cellulitis, or necrotic-appearing skin requires rapid surgical intervention.
- Necrotic skin requires examination of fascial planes to exclude necrotizing fasciitis.
- Crepitus requires immediate debridement of tissue.
- Pain disproportionate to the physical examination or severe pain on passive movement of the extremities may indicate necrotising fasciitis and requires prompt evaluation.
- Bacteremia: if the invading bacteria have the necessary virulence factors, bacteremia can develop into sepsis and/or seeding of internal organs and prosthetic devices.
- Circumferential cellulitis may impede blood flow or increase pressure distally, resulting in a compartment syndrome.
- Toxin release:
- Even when infection is localized in healthy patients, some strains of gram-positive bacteria, such as group A beta-haemolytic Streptococcus and Staphylococcus aureus, may produce systemic toxins.7
- Toxin-mediated disease is a serious infection causing septic shock, hypotension, and organ failure.
- In adults, the mortality rate of toxin-mediated disease is approximately 50%.
- Local complications: abscesses, superinfection, lymphangitis (lymphatic involvement can lead to obstruction and damage of the lymphatic system that predisposes to recurrent cellulitis), thrombophlebitis, gas-forming cellulitis, necrotizing fasciitis.
- Uncomplicated cellulitis has an excellent prognosis.
- Treatment without hospital admission is effective for well over 90% of patients.
- Of those who fail outpatient therapy or require admission initially, intravenous antibiotics are very effective.
Document References
- Cunningham D; Cellulitis. eMedicine July 2006.
- Stulberg DL, Penrod MA, Blatny RA; Common bacterial skin infections. Am Fam Physician. 2002 Jul 1;66(1):119-24. [abstract]
- Manfredi R, Calza L, Chiodo F; Epidemiology and microbiology of cellulitis and bacterial soft tissue infection during HIV disease: a 10-year survey. J Cutan Pathol. 2002 Mar;29(3):168-72. [abstract]
- Falagas ME, Vergidis PI; Narrative review: diseases that masquerade as infectious cellulitis. Ann Intern Med. 2005 Jan 4;142(1):47-55. [abstract]
- BNF; Section 5.1; Antibacterial drugs.
- Health Protection Agency; Antibiotic guidance for primary care.
- Thomas S, Cunha BA; Group B streptococcal toxic shock-like syndrome with fulminant cellulitis. Heart Lung. 1996 Nov-Dec;25(6):497-9. [abstract]
Internet and Further Reading
- Cellulitis, Prodigy (2005)
- Consensus Document on the Management of Cellulitis in Lymphoedema, British Lymphology Society (2006)
DocID: 1921
Document Version: 20
DocRef: bgp24915
Last Updated: 1 Jan 2007
Review Date: 31 Dec 2008
Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.
Related pages in Patient UK
Your Experience (^ top of page)
Please add your experience about this condition / medicine
View patient experiences and discussions about this condition / medicine (107 there)Information leaflets related to this topic (^ top of page)
Boils, Carbuncles and Furunculosis
CellulitisPatient Support related to this topic (^ top of page)
The 'Lee Spark' NF FoundationMedical reference articles in PatientPlus related to this topic (^ top of page)
Ecthyma
Panton-Valentine Leukocidin (PVL) Positive Staph. AureusUK guidelines related to this topic (^ top of page)
Guidelines on CellulitisLinks to other selected websites related to this topic (^ top of page)
CellulitisOther - Useful resources (^ top of page)
Pictures, diagrams, photos, images, etc.Evidence based medicine
Online textbooks and journals
A-Z of UK Guidelines
A-Z of Online Videos
Medline
Other good health sites
Medical equipment products related to this topic (^ top of page)

Books related to this topic (^ top of page)

Want to search some more? Use the Google Search box below to search our site.

Would you like to try our advanced on-line knowledge support system designed to provide professionals with relevant up to date information about recognition and management of disease or take the Mentor Challenge?
Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.
